Qube Research & Technologies LTD Volitionrx LTD Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.59 - $0.91 $59 - $91
-100 Reduced 1.58%
6,244 $3,000
Q4 2023

Feb 13, 2024
BUY
$0.55 - $0.88 $3,488 - $5,580
6,342 Added 317100.0%
6,344 $4,000
Q3 2023

Nov 13, 2023
BUY
$0.69 - $1.53 $1 - $3
2 New
2 $0
Q4 2022

Feb 14, 2023
BUY
$1.39 - $2.6 $41,018 - $76,726
29,510 New
29,510 $71,000

Others Institutions Holding VNRX

# of Institutions
26
Shares Held
17.8M
Call Options Held
41K
Put Options Held
100
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email